A New Class of Cancer Drugs May Be Less Toxic – NYTimes.com

A good overview piece on one of the more promising treatments in cancer treatment: targeted therapy, harnessing antibodies to deliver ‘toxic payloads’  to cancer cells, thereby largely sparing health cells, and without the major side effects of conventional chemo and radiation therapies.

Current drugs include Adcetris, for Hodgkin’s Lymphoma, and T-DM1 for breast cancer, with about 25 other drugs in clinical trials. Pretty amazing technology.

A New Class of Cancer Drugs May Be Less Toxic – NYTimes.com.

Advertisements

One thought on “A New Class of Cancer Drugs May Be Less Toxic – NYTimes.com

  1. Just finished my second infusion with adcetris. I am feeling so much better than before I decided to try this chemo. I made the decision to do this rather than be turned over to hospice. My next chemo is October 3, 2012. Has anyone had an experience with this drug and been in the clinical trials?

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s